April 16, 2014 10:44 PM ET

Pharmaceuticals

Company Overview of Emcure Pharmaceuticals Limited

Executive Profile

Mahendra Patel

Former Non-Executive Director, Emcure Pharmaceuticals Limited
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 1 different industries.

----

Background

Dr. Mahendra Patel served as a Director at Emcure Pharmaceuticals Ltd. since January 2005 until April 29, 2011. Dr. Patel holds 30 patents to his credit and combines an all round expertise in the areas of APIs, formulation development, Bio-equivalence studies, Intellectual Property, and the Regulatory Process. He set up and successfully led his own generics company, Invamed in the US, which was later acquired by Sandoz. Dr. Patel has also been associated with large trans-national ...

Corporate Headquarters

Emcure House
Pune, Maharashtra 411026

India

Phone: 91 20 2712 0084
Fax: 91 20 3061 0111

Board Members Memberships

2005-2011
Former Non-Executive Director

Education

PhD
University of Wisconsin - Madison

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Emcure Pharmaceuticals Limited, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.